Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 25/2/2021
SIETES contiene 93212 citas

 
 
 1 a 20 de 218 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Goldacre B. The WHO joint statement from funders on trials transparency. BMJ 2017;357:j2816. [Ref.ID 101660]
2. Cita con resumen
Hutton B, Catalá-López F, Moher D. La extensión de la declaración PRISMA para revisiones sistemáticas que incorporan metaanálisis en red: PRISMA-NMA. Med Clin (Barc) 2016;147:262-6. [Ref.ID 100724]
3. Cita con resumen
Chan A-W, Telzlaff JM, Altman DG, Laupacis A, Gotzche PC, Krieza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar WR, Summerskill WSM, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200-7. [Ref.ID 94901]
5.Tiene citas relacionadas Cita con resumen
Piaggio G, Elbourne DR, Pocock SJ, Evans SJW, Altman DG, for the CONSORT Group. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA 2012;308:2594-604. [Ref.ID 94276]
6.
Campbell MK, Piaggio G, Elbourne DR, Altman DG, for the CONSORT Group. Consort 2010 statement: extension to cluster randomised trials. BMJ 2012;345:19-22. [Ref.ID 94007]
7.
Calvert M, Blazeby J, Revicki D, Moher D, Brundage M. Reporting quality of life in clinical trials: a CONSORT extension. Lancet 2011;378:1684-5. [Ref.ID 91812]
8. Cita con resumen
Roseman M, Milette K, Bero LA, Coyne JC, Lexchin J, Turner EH, Thombs BD. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. JAMA 2011;305:1008-17. [Ref.ID 90287]
9.Tiene citas relacionadas
Chen Y-L, Yang KH. CONSORT 2010. Lancet 2010;376:230. [Ref.ID 88919]
10.Tiene citas relacionadas
Reveiz L, Krleza-Jeric K. CONSORT 2010. Lancet 2010;376:230. [Ref.ID 88918]
11.Tiene citas relacionadas Cita con resumen
Saint-Raymond A, Hill S, Martines J, Bahl R, Fontaine O, Bero L. CONSORT 2010. Lancet 2010;376:229-30. [Ref.ID 88917]
12.Tiene citas relacionadas Cita con resumen
Clarke M, Hopewell S, Chalmers I. Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting. Lancet 2010;376:20-1. [Ref.ID 88855]
13.Tiene citas relacionadas Cita con resumen
Clark S, Horton R. Putting research into context - revisited. Lancet 2010;376:10-1. [Ref.ID 88854]
14.Enlace a cita original Cita con resumen
Shulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010;152:726-32. [Ref.ID 88692]
15. Cita con resumen
16.Tiene citas relacionadas Cita con resumen
Schulz KF, Altman DG, Moher D, Fergusson D. CONSORT 2010 changes and testing blindness in RCTs. Lancet 2010;375:1144-6. [Ref.ID 88230]
17.Enlace a cita originalTiene citas relacionadas Cita con resumen
Anónimo. CONSORT 2010. Lancet 2010;375:3 de abril. [Ref.ID 88228]
18.Tiene citas relacionadas
Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:698-702. [Ref.ID 88189]
19.Tiene citas relacionadas Cita con resumen
Hopewell S, Dutton S, Yu LM, Chan A-W, Altman DG. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ 2010;340:697. [Ref.ID 88188]
20.Tiene citas relacionadas
Antes G. The new CONSORT statement. BMJ 2010;340:666-7. [Ref.ID 88182]
Seleccionar todas
 
 1 a 20 de 218 siguiente >>